These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 8392601
1. Functional domains of the simian foamy virus type 1 transcriptional transactivator (Taf). Mergia A, Renshaw-Gegg LW, Stout MW, Renne R, Herchenröeder O. J Virol; 1993 Aug; 67(8):4598-604. PubMed ID: 8392601 [Abstract] [Full Text] [Related]
2. The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function. Venkatesh LK, Chinnadurai G. J Virol; 1993 Jul; 67(7):3868-76. PubMed ID: 8389909 [Abstract] [Full Text] [Related]
3. Characterization of the internal promoter of simian foamy viruses. Campbell M, Renshaw-Gegg L, Renne R, Luciw PA. J Virol; 1994 Aug; 68(8):4811-20. PubMed ID: 8035481 [Abstract] [Full Text] [Related]
4. cis-acting regulatory regions in the long terminal repeat of simian foamy virus type 1. Mergia A, Pratt-Lowe E, Shaw KE, Renshaw-Gegg LW, Luciw PA. J Virol; 1992 Jan; 66(1):251-7. PubMed ID: 1309244 [Abstract] [Full Text] [Related]
5. The Bel1 protein of human foamy virus contains one positive and two negative control regions which regulate a distinct activation domain of 30 amino acids. Lee CW, Chang J, Lee KJ, Sung YC. J Virol; 1994 Apr; 68(4):2708-19. PubMed ID: 8139046 [Abstract] [Full Text] [Related]
11. Hydrophobic cluster analysis predicts an amino-terminal domain of varicella-zoster virus open reading frame 10 required for transcriptional activation. Moriuchi H, Moriuchi M, Pichyangkura R, Triezenberg SJ, Straus SE, Cohen JI. Proc Natl Acad Sci U S A; 1995 Sep 26; 92(20):9333-7. PubMed ID: 7568128 [Abstract] [Full Text] [Related]
12. Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains. Carruth LM, Hardwick JM, Morse BA, Clements JE. J Virol; 1994 Oct 26; 68(10):6137-46. PubMed ID: 8083955 [Abstract] [Full Text] [Related]
13. Functional organization of the Bel-1 trans activator of human foamy virus. He F, Sun JD, Garrett ED, Cullen BR. J Virol; 1993 Apr 26; 67(4):1896-904. PubMed ID: 8383217 [Abstract] [Full Text] [Related]
14. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein. Fukuma T, Enomoto N, Marumo F, Sato C. Hepatology; 1998 Oct 26; 28(4):1147-53. PubMed ID: 9755255 [Abstract] [Full Text] [Related]
15. Transactivation of the two promoters of SFV-3 by different mechanisms. Renne R, Fleps U, Luciw PA, Neumann-Haefelin D. Virology; 1996 Jul 15; 221(2):362-7. PubMed ID: 8661448 [Abstract] [Full Text] [Related]
17. Functional dissection of the human spumaretrovirus transactivator identifies distinct classes of dominant-negative mutants. Venkatesh LK, Yang C, Theodorakis PA, Chinnadurai G. J Virol; 1993 Jan 15; 67(1):161-9. PubMed ID: 8380068 [Abstract] [Full Text] [Related]
18. Identification of the Epstein-Barr virus nuclear antigen 2 transactivation domain. Horvath GC, Schubach WH. Biochem Biophys Res Commun; 1993 Feb 26; 191(1):196-200. PubMed ID: 8383488 [Abstract] [Full Text] [Related]
19. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16. Hardwick JM, Tse L, Applegren N, Nicholas J, Veliuona MA. J Virol; 1992 Sep 26; 66(9):5500-8. PubMed ID: 1323708 [Abstract] [Full Text] [Related]
20. Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. Winkler I, Bodem J, Haas L, Zemba M, Delius H, Flower R, Flügel RM, Löchelt M. J Virol; 1997 Sep 26; 71(9):6727-41. PubMed ID: 9261397 [Abstract] [Full Text] [Related] Page: [Next] [New Search]